Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Weens

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1977
An automated method of differential red blood cell classification with application to the diagnosis of anemiaJ W Bacus, J H Weens
Scandinavian Journal of Haematology|March 1, 1982
Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrateB C McLeod, R J Sassetti, J H Weens, et al.
American Journal of Clinical Oncology|December 1, 1991
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot studyA S Spiers, J H Weens, J M Rowe, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1977
An automated method of differential red blood cell classification with application to the diagnosis of anemiaJ W Bacus, J H Weens
Scandinavian Journal of Haematology|March 1, 1982
Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrateB C McLeod, R J Sassetti, J H Weens, et al.
American Journal of Clinical Oncology|December 1, 1991
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot studyA S Spiers, J H Weens, J M Rowe, et al.
Pageof 1